Loading

Important announcement

The current page will cease to exist as of June 2019. Data, information and documents related to our grants are now available on the Global Fund Data Explorer. Please use this platform.

Overview

With a population of more than 1.2 billion, India is home to one-sixth of the world’s population. The country accounts for about a quarter of the global TB burden. India is also the country with the second-highest number of estimated HIV-TB coinfections, after South Africa. However, the government of India is committed to fighting the disease. In March 2017, the government announced a new plan to end TB in the country by 2025. The Global Fund is supporting the country with investments to help it meet its goals. HIV in India is mainly concentrated among key populations, but because of its huge population, the country has a large number of people living with HIV, at about 2.1 million. Nevertheless, the country has recorded great progress against the disease. Since 2010, new HIV infections have decreased by 46 percent and AIDS-related deaths have decreased by 22 percent. India has also made significant progress in the fight against malaria, halving the number of malaria cases since 2000, and making great progress toward elimination. However, the spread of artemisinin resistance from the Greater Mekong sub-region remains a threat to India’s efforts to eliminate malaria.

Investments to Date

Component Signed Committed Disbursed

Disbursements by Component

Documentation

For documents pertaining to a specific grant, please select a grant from the list.

Country Results Profiles